Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels

Authors: Rikken, Sem A.O.F. ^{a, b, c}, Gibson, C. Michael ^{c, d, ∗}, Bahit, M. Cecilia ^{c, e}, Duffy, Danielle ^f, Chi, Gerald ^d, Korjian, Serge ^{c, d}, Mohammadnia, Niekbachsh ^g, White, Harvey ^{c, h}, Anschuetz, Gaya ^f, Kingwell, Bronwyn A. ⁱ, Ophuis, Ton Oude ^j, Nicolau, Jose C. ^k, Lopes, Renato D. ^{l, m}, Lewis, Basil S. ^{c, n, o}, El Messaoudi, Saloua ^g, Vinereanu, Dragos ^p, ten Berg, Jurriën M. ^{a, b, q}, Goodman, Shaun G. ^{r, s, t}, Bode, Christoph ^u, Steg, P. Gabriel ^{c, v}, Libby, Peter ^w, Bainey, Kevin R. ^{c, x}, van 't Hof, Arnoud W.J. ^{b, p, y}, Ridker, Paul M. ^z, Mahaffey, Kenneth W. ^aa, Nicholls, Stephen J. ^{c, ab}, Mehran, Roxana ^ac, Harrington, Robert A. ^ad, Cornel, Jan H. ^{c, g, ae}

Source: In JACC: Advances May 2025 4(5)

Medically Treated Nonischemic Thin-Cap Fibroatheroma Lesions Versus Fractional Flow Reserve-Guided Complete Revascularization in Diabetic Patients

Authors: Hommels, Tobias M., Hermanides, Renicus S., Fabris, Enrico, Malinowski, Krzysztof P., Berta, Balázs, Roleder, Tomasz, Alfonso, Fernando, De Luca, Giuseppe, Oemrawsingh, Rohit M., Wojakowski, Wojciech, van ‘t Hof, Arnoud W.J., Kedhi, Elvin

Source: In Journal of the Society for Cardiovascular Angiography & Interventions March 2024 3(3) Part A

Percutaneous coronary intervention with drug-eluting stents versus coronary bypass surgery for coronary artery disease: A Bayesian perspective

Authors: Kawczynski, Michal J., Gabrio, Andrea, Maessen, Jos G., van ’t Hof, Arnoud W.J., Brophy, James M., Gollmann-Tepeköylü, Can, Sardari Nia, Peyman, Vriesendorp, Pieter A., Heuts, Samuel

Source: In The Journal of Thoracic and Cardiovascular Surgery August 2024

Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial infarction – A post hoc analysis of the cel-02 phase IIa study

Authors: Rikken, Sem A.O.F., Bor, Willem L., Selvarajah, Abi, Zheng, Kai L., Hack, Amy P., Gibson, C. Michael, Granger, Christopher B., Bentur, Ohad S., Coller, Barry S., van ’t Hof, Arnoud W.J., ten Berg, Jurriën M.

Source: In American Heart Journal August 2023 262:75-82

Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial

Authors: Rikken, Sem A.O.F. ^*, Selvarajah, Abi ^*, Hermanides, Renicus S., Coller, Barry S., Gibson, C. Michael, Granger, Christopher B., Lapostolle, Frédéric, Postma, Sonja, van de Wetering, Henri, van Vliet, Risco C.W., Montalescot, Gilles, ten Berg, Jurriën M., van ’t Hof, Arnoud W.J.

Source: In American Heart Journal April 2023 258:119-128

Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation

Authors: van Ginkel, Dirk Jan, Bor, Willem L., Veenstra, Leo, van 't Hof, Arnoud W.J., Fabris, Enrico

Source: In European Journal of Internal Medicine July 2022 101:14-20

Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction

Authors: Heuts, Samuel, Denessen, Ellen J.S., Daemen, Jean H.T., Vroemen, Wim H.M., Sels, Jan-Willem, Segers, Patrique, Bekers, Otto, van ‘t Hof, Arnoud W.J., Maessen, Jos G., van der Horst, Iwan C.C., Mingels, Alma M.A.

Source: In The American Journal of Cardiology 15 January 2022 163:25-31

Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI

Authors: Tavenier, Anne H., Hermanides, Renicus S., Fabris, Enrico, Angiolillo, Dominick J., van 't Hof, Arnoud W.J.

Source: In International Journal of Cardiology 1 April 2021 328:40-45

NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial

Authors: Fabris, Enrico, ten Berg, Jurrien M., Hermanides, Renicus S., Ottervanger, Jan Paul, Dambrink, Jan Henk E, Gosselink, AT Marcel, Sinagra, Gianfranco, Koopmans, Petra C., Giannitsis, Evangelos, Hamm, Christian, van ’t Hof, Arnoud W.J.

Source: In American Heart Journal March 2021 233:78-85

MINOCA: The caveat of absence of coronary obstruction in myocardial infarction

Authors: Vranken, Nousjka P.A., Pustjens, Tobias F.S., Kolkman, Evelien, Hermanides, Renicus S., Bekkers, Sebastiaan C.A.M., Smulders, Martijn W., van Cauteren, Yvonne J.M., Heijman, Jordi, Rasoul, Saman, Ottervanger, Jan P., van 't Hof, Arnoud W.J.

Source: In IJC Heart & Vasculature August 2020 29

Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome

Authors: van Dongen, Dominique N., Fokkert, Marion J., Tolsma, Rudolf T., Badings, Erik A., van der Sluis, Aize, Slingerland, Robbert J., van ‘t Hof, Arnoud W.J., Ottervanger, Jan Paul

Source: In The American Journal of Cardiology 15 November 2018 122(10):1610-1616

Comparison of Outcomes and Intervention Among Patients With Non–ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non–Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial)

Authors: Badings, Erik A. ^*, Hermanides, Renicus S., The, Salem H.K., Dambrink, Jan-Henk E., Rasoul, Saman, Van Wijngaarden, Jan, Van 't Riet, Esther, Kolkman, Evelien, Remkes, Wouter S., Tjeerdsma, Geert, Van Der Wielen, Marloes L.J., Lok, Dirk J.A., Suryapranata, Harry, Van 't Hof, Arnoud W.J.

Source: In The American Journal of Cardiology 15 May 2018 121(10):1123-1128

One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent

Authors: Kalkman, Deborah N., Woudstra, Pier, den Heijer, Peter, Menown, Ian B.A., Erglis, Andrejs, Suryapranata, Harry, Arkenbout, Karin E., Iñiguez, Andrés, van ’t Hof, Arnoud W.J., Muller, Philippe, Tijssen, Jan G., de Winter, Robbert J.

Source: In International Journal of Cardiology 1 January 2017 226:60-64

Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial

Authors: Camaro, Cyril, Damen, Sander A.J., Brouwer, Marc A., Kedhi, Elvin, Lee, Stephan W., Verdoia, Monica, Barbieri, Lucia, Rognoni, Andrea, van t Hof, Arnoud W.J., Ligtenberg, Erik, de Boer, Menko-Jan, Suryapranata, Harry, De Luca, Giuseppe

Source: In American Heart Journal August 2016 178:37-44

1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry

Authors: Woudstra, Pier, Kalkman, Deborah N., den Heijer, Peter, Menown, Ian B.A., Erglis, Andrejs, Suryapranata, Harry, Arkenbout, Karin E., Iñiguez, Andrés, van 't Hof, Arnoud W.J., Muller, Philippe, Tijssen, Jan G.P., de Winter, Robbert J.

Source: In JACC: Cardiovascular Interventions 13 June 2016 9(11):1127-1134

CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study

Authors: Bergmeijer, Thomas O., Janssen, Paul W.A., Schipper, Jurjan C., Qaderdan, Khalid, Ishak, Maycel, Ruitenbeek, Rianne S., Asselbergs, Folkert W., van ‘t Hof, Arnoud W.J., Dewilde, Willem J.M., Spanó, Fabrizio, Herrman, Jean-Paul R., Kelder, Johannes C., Postma, Maarten J., de Boer, Anthonius, Deneer, Vera H.M., ten Berg, Jurriën M.

Source: In American Heart Journal July 2014 168(1):16-22

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Authors: Ng, Sunanto, Ottervanger, Jan Paul, van 't Hof, Arnoud W.J., de Boer, Menko-Jan, Reiffers, Stoffer, Dambrink, Jan-Henk E., Hoorntje, Jan C.A., Gosselink, A.T. Marcel, Suryapranata, Harry

Source: In International Journal of Cardiology 25 May 2013 165(3):523-527

Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.

Authors: Curry, Benjamin J., Rikken, A.O.F. Sem, Gibson, C. Michael, Granger, Christopher B., van 't Hof, Arnoud W.J., ten Berg, Jurriën M., Jennings, Lisa K.

Source: Journal of Thrombosis & Thrombolysis; Nov2023, Vol. 56 Issue 4, p499-510, 12p

Risk of bleeding after prehospital administration of high dose tirofiban for ST Elevation Myocardial Infarction

Authors: Hermanides, Renicus S., Ottervanger, Jan Paul, Dambrink, Jan-Henk E., Dill, Thorsten, van Houwelingen, Gert, ten Berg, Jurrien M., Kolkman, Evelien, Hamm, Christian, van ‘t Hof, Arnoud W.J.

Source: In International Journal of Cardiology 17 May 2012 157(1):86-90

Prehospital triage in the ambulance reduces infarct size and improves clinical outcome

Authors: Postma, Sonja, Dambrink, Jan-Henk E., de Boer, Menko-Jan, Gosselink, A.T. Marcel, Eggink, Gerrit J., van de Wetering, Henri, Hollak, Frans, Ottervanger, Jan Paul, Hoorntje, Jan C.A., Kolkman, Evelien, Suryapranata, Harry, van 't Hof, Arnoud W.J.

Source: In American Heart Journal February 2011 161(2):276-282